Terumo to Make Full Entry into Market for Catheter-based Treatment for Cerebral Vascular Disease.Tokyo, Japan, Mar 1, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Terumo has signed an agreement with MicroVention of California, whereby Terumo will acquire the US company as its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. by the end of March. MicroVention specializes in the production of hydrogel-coated and bare platinum coils for the treatment of cerebral cerebral /cer·e·bral/ (se-re´bral) (ser´e-bral) pertaining to the cerebrum. cer·e·bral adj. Of or relating to the brain or cerebrum. vascular aneurysms, and has about a 15% share of the global market. With the US company under its arm, Terumo aims to make a full entry into the field of catheter-based treatment for cerebral vascular diseases vascular diseases, n.pl diseases of the peripheral circulatory system. . Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion